Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Qingre Granules (感冒清热颗粒) is a well-established Traditional Chinese Medicine (TCM) product manufactured by Henan Purui Pharmaceutical. It is formulated based on a classic herbal recipe intended to treat the wind-cold pattern of the common cold and upper respiratory tract infections. The preparation typically contains eleven medicinal herbs, including *Schizonepeta tenuifolia*, *Mentha haplocalyx*, and *Saposhnikovia divaricata*, which work together to induce sweating, dispel cold, and alleviate symptoms such as fever, headache, chills, and body aches. As an over-the-counter (OTC) medication in China, it is widely recognized for its efficacy in the early stages of viral respiratory infections and is characterized by its antipyretic and anti-inflammatory properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ganmao qingre keli.